氨基胍对糖尿病大鼠非酶糖化和细胞凋亡的影响(3)
| 第1页 |
参见附件。
[2] 叶山东,朱禧星.氨基胍的作用机制及其在糖尿病慢性并发症中的应用.国外医学• 生理病理科学与临床分册, 1998, 18(2): 168-170.
[3] 张圣明, 李建华, 崔为法, 等.慢性再生障碍性贫血患者骨髓细胞形态的透射电镜观察.中华血液学杂志, 1990, 11(5): 253-254.
[4] Soulis-Liparota T, Cooper M, Papazoglou D, et al.Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat.Diabetes, 1991, 40(10): 1328-1334.
[5] Harrington CR, Colaco CA.Alzheimer's disease.A glycation connection.Nature, 1994, 370(6487): 247-248.
[6] 叶山东.氨基胍的作用机制及其在糖尿病慢性并发症中的应用.国外医学• 生理病理科学与临床分册, 1998, 18(2): 168-170.
[7] 吕学爱, 关广聚, 晋运玲,等.氨基胍对糖尿病大鼠肾脏非酶糖基化的抑制作用.泰山医学院学报, 2004, 25(2): 176-179.
[8] Sano K, Fujigaki Y, Miyaji T, et al.Role of apoptosis in uranyl acetate-induced acute renal failure and acquired resistance to uranyl acetate.Kidney Int, 2000, 57(4): 1560-1570.
[9] Makino H, Kashihara N, Sugiyama H, et al.Phenotypic modulation of the mesangium reflected by contractile proteins in Diabetes.Diabetes, 1996,45(4): 488-495.
[10] Brownlee M.Biochemistry and molecular cell biology of Diabetic complications.Nature, 2001, 414(6865): 813-820.
您现在查看是摘要介绍页，详见PDF附件。